Zeynep YAPAN EMREN, Ahmet ERSEÇGİN, Ferhat Siyamend YURDAM, Oktay ŞENÖZ

ACİL GEÇİCİ KALP PİLİ TAKILAN HASTALARIN KLİNİK ÖZELLİKLERİ VE HASTANE İÇİ MORTALİTE ORANLAR

Giriş: Geçici kalp pili(GKP) uygulaması birçok bradiaritminin acil tedavisinde hayat kurtarıcı role sahiptir.Özellikle ilaçların etkisiz olduğu infra nodal atriyoventriküler blokların (AVB) acil tedavisi için tek seçenektir.Bu çalışmada,kliniğimizde acil GKP uygulanan hastaların klinik özelliklerini ve hastane içi mortalite oranlarını tespit etmeyi amaçladık. Gereç ve Yöntem:Ekim 2016-Haziran 2021 tarihleri arasında kliniğimizde acil GKP tak ılan 229 hasta çalışmaya dahiledildi. Hastaların klinik ve laboratuvar özellikleri hastane kayıtları vasıtasıyla geriye dönük olarak incelendi. Bulgular: Hastaların 225’ine bradiaritmi nedeniyle, 4’üne ise taşiaritmi nedeniyle (over-drive pacing amaçlı) GKP implante edildi.GKP gerektiren bradiaritmi nedenleri s ırasıyla; idiopatik (%33.3), ilaçlar (%30.6), iskemi (%30.6), hiperpotasemi (%4.9) ve konjenital at riyoventriküler bloktu (%0.4). En s ık bradikardi türü 2. ve 3. derece atriyoventriküler bloklardı (%77.3). Bradiaritmi nedeniyle GKP tak ılan hastaların 110 (%48.9)’una kalıcı kalp pili implantasyonu gerekti. Hastaların 35 (%15.3)’inde hastane içi mortalite gelişti. Mortalite oranı, iskemi ve hiperpotasemi gruplarında diğerlerine göre anlamlı olarak daha yüksekti (p

CLINICAL FEATURES AND IN-HOSPITAL MORTALITY RATE OF PATIENTS WİTH EMERGENCY TEMPORARY PACEMAKER

Introduction:Temporary pacemaker (TPM) application has a life-saving role in the emergency treatment of many bradyarrhythmias. Especially, it is the only option for the emergency treatment of infranodal atrioventricular blocks (AVB) where drugs are ineffective.In this study,we aimed to det ermine the clinical features and in-hospital mortality rates of patients who underwent emergency TPM in our clinic. Material and Method: Between October 2016 and June 2021, 229 patients who underwent emergency TPM in our clinic were included in the study. The clinical and laboratory characteristics of the patients were examined retrospectively through hospital records. Results: TPM was implanted in 225 patients for bradyarrhythmia and 4 for tachyarrhythmia (forover-drive pacing). The causes of bradyarrhythmia requiring TPM were idiopathic (33.3%), drugs (30.6%), ischemia (30.6%), hyperkalemia (4.9%), and congenital atrioventricular block (0.4%). The most common type of bradycardia was 2nd and 3nd degree atrioventricular blocks (77.3%). Permanent pacemaker implantation was required in 110 (48.9%) of the patients with TPM due to bradyarrhythmia. In-hospital mortality developed in 35 (15.3%) of the patients. Mortality rate was significantly higher in the ischemia and hyperkalemia groups compared to the others (p

PDF

___

1. Furman S, Robinson G. Theuse of an intracardiac pacemaker in the correction of total heartblock. Surg Forum 1958; 9: 245-8.
2. Ferguson JD, Banning AP, Bashir Y. Randomised trial of temporary cardiac pacing with semirigid and balloon flotation electrode catheters. Lancet 1997; 349(9069):1883.
3. Brignole M, Auricchio A, Baron Esquivias G, Bordachar P, Boriani G, Breithar dt O et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Forc e on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collabor ation with the European Heart Rhythm Association (EHRA). Eur Heart J 2013; 34(29): 2281-329.
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes N.A, Freedman R, Gettes L et al. 2012 ACCF/AHA/HRS focused update in corporated in to the ACCF/ AHA/HRS 2008 guidelines for device based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013; 127(3): e283-e352.
5. Harrigan RA, Chan TC, Moonblatt S,Vilke G, Ufberg J. Temporary transvenous pacemaker placement in the Emergency Department. J Emerg Med 2007; 32(1): 105-11.
6. Kowey PR, Engel TR. Overdrive pacing for ventricular tachyarrhythmias: a reassessment. Ann Intern Med 1983; 99(5): 651-6.
7. Blommaert D, Gonzalez M, Mucumbitsi J,Gurne O, Evrard P, Buche M et al. Effective prevention of atrial fibrillation by continuous atrial over drive pacing after coronary artery bypass surgery. J Am Coll Cardiol 2000; 35(6): 1411-5.
8. Jowett NI, Thompson DR, Pohl JE. Temporary transvenous cardiac pacing: 6 years experience in one coronary care unit. Post Grad Med J 1989; 65(762): 211- 5.
9. Berilgen R, Yesil I, Ertas F, Kocabas U, Duzel B, Eren N et al.Geçici kalp pili implante edilen hastaların klinik özellikleri, altta yatan hastalıkları ve hastane içi mortalite oranları. Journal of Clinical and Experimental Investigations 2013; 4(2): 180-3.
10. López Ayerbe J, Villuendas Sabaté R, Ga rcía García C, Leor OR, Perez MG, A badal AC et al. Temporary pacemakers: current use and complications. Rev Esp Cardiol 2004; 57(11): 1045-52.
11. Ochoa FJ, López JC, Ramalle-Gómara JM. Marcapasosendocavitarioprovisional. Emergencias 1997; 9(5): 278-81.
12. Jou YL, Hsu HP, Tuan TC,Wang KL, Lin YJ, Lo LW et al. Trends of temporary pacemaker ımplant and underlying disease substrate. Pacing and Clinical Electrophysiology 2010; 33(12): 1475-84.
13. Inci S, Zeren G, Aktas H, Nar G, Duzgun A, Cal ıskan K et al. Geçici kalp pili tak ılan hastaların etyolojik, demografik, klinik özellikleri ve komplikasyonları. MN Kardiyoloji 2015; 22(4): 186-91.
14. Barra SNCB, Providencia R, Paiva L,Nascimento J, Marques AL. A review on advanced atrioventricular block in young or middle-aged adults. Pacing and Clinical Electrophysiology 2012; 35 (11): 1395-405.
15. Essebag V, Hadjis T, Platt RW, Pilote L. Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J Am Coll Cardiol 2003; 41(2): 249–54.
16. Bigger JT Jr, Reiffel JA. Sick sinus syndrome. Annu Rev Med 1979; 30(1): 91–118.
17. Friedman PL, Stevenson WG. Proarrhythmia. Am J Cardiol 1998; 82(8): 50–8.
18. Zipes DP. Proarrhythmic effect of antiarrhythmic drugs. Am J Cardiol 1987; 59(11): E26–31.
19. Kawabata M, Yokoyama Y, Sasaki T, Tao S, Ihara K, Shirai Y et al. Severe iatrogenic bradycardia related to the combine duse of beta-blocking agents and sodium channel blockers.Clinpharmacol 2015; 7: 29–36.
20. Krum H, Roecker EB, Mohacsi P,RouleauJL, Tendera M, Coats A et al. Carvedilol pr ospective randomizedcumulative survival (COPERNICUS) Study Group. Effects of initiating carv edilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA 2003; 289(6): 712–8.
21. Hjalmarson A, Goldstein S, Fagerberg B,Wedel H, Waagstein F, Kjekshus J et al. Effects of controlled release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure. JAMA 2000; 283(10): 1295–302.
22. Ullah F, Din IU, Adil I, Ali U, Khan MA, Abbas F. High deg ree av block in patients presenting with acute myocardial infarction. Pak Heart J 2019; 52(3): 235-9.
23. Misumida N, Ogunbayo GO,Catanzaro J, Etaee F, Kim SM, Abdel-Latif A et al. Contemporary practice pattern of permanent pacing for conduction disorders in inferior ST-elevation myocardial infarction.Clinical Cardiology 2019; 42(8): 728–34.
24. Knudsen MB, Thogersen AM, Hjortshoj SP, Riahi S.The impact of drug discontinuat ion in patients treated with temporary pacemaker due to atrioventricular block. Journal of Cardiovascular Electrophysiology 2013; 24 (11): 1255-8.
25. Zeltser D, Justo D, Halkin A, Rosso R, Ish-Shalom M, Hochenberg M et al. Drug-induced atri oventricular block: prognosis after discontinuation of the culprit drug. J Am CollCardiol 2004; 44(1): 105–8.
26. Metkus TS, Schulman SP, Marine JE, Eid SM. Complications and outcomes of temporary transvenous pacing an analysis of > 360,000 patients from the national ınpatient sample. CHEST 2019; 155(4): 749-57.
27. Berger PB, Ryan TJ. Inferior myocardial ınfarction high-risk subgroups. Circulation 1990; 81(2):401-11.
28. Felah E, Samia B, Mariem H, Ben-Amor S, Chargui S, Amiri ML, et al. Hyperkalemia: epidemiology and management. Nephrology Dialysis Transplantation 2020; 35(3) : P0318.
29. Montford JR, Linas S. How Dangerous Is Hyperkalemia? J Am Soc Nephrol 2017; 28(11): 3155–65.
30. Gammage MD. Electrophysiology: Temporary cardiac pacing. Heart 2000; 83(6): 715-20.